Navigation Links
Genesis Pharmaceuticals Received New Purchase Orders Worth $12 Million
Date:9/11/2008

LAIYANG, China, Sept. 11 /Xinhua-PRNewswire-FirstCall/ -- Genesis Pharmaceuticals Enterprises, Inc. (OTC Bulletin Board: GNPH) ("Genesis" or the "Company"), a leading pharmaceutical company in the People's Republic of China, today announced that the Company received purchase orders for a total value of approximately $12 million over the next 12 months from over 800 wholesale distributors at the 43rd Annual New Drugs Conference (the "Conference") sponsored by China Health Tech Forum 2008.

The 43rd Annual New Drugs Conference was held on September 3rd - 5th in Yantai International Expo Center, Shandong Province. The purpose of this industry Conference was to allow pharmaceutical companies in China with new and innovative products to meet and exchange ideas, and to allow pharmaceutical companies to introduce their products to distributors. Genesis distributed a large number of Company brochures at the Conference and received numerous inquiries from distributors.

The Company's newly developed Radix Isatidis Dispersible Tablets, an herbal-based traditional Chinese medicine, received the highest number of orders, over 60% of the total value of the purchase orders.

"We are pleased that the 43rd Annual New Drugs Conference was such a success for the Company. We believe that these new purchase orders from these distributors will increase our presence in the Chinese over the counter pharmaceuticals market," said Mr. Cao Wubo, Chairman and CEO of Genesis Pharmaceuticals Enterprises. "We hope to expand our market share and get even greater brand recognition in China in the future by bringing new and innovative products to market."

About Genesis Pharmaceuticals Enterprises, Inc.

Genesis Pharmaceuticals Enterprises, Inc. is a U.S. public company engaged in the research, development, production, marketing and sales of pharmaceutical products in the People's Republic of China. Its operations are located in Northeast China in an Economic Dev
'/>"/>

SOURCE Genesis Pharmaceuticals Enterprises, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Pathway links inflammation, angiogenesis and breast cancer
2. EURYI project to understand how the brain wires during embryogenesis
3. DNA damage response confers a barrier for viral tumorigenesis
4. ThermoGenesis Announces 510(k) Clearance for AutoXpress(TM) Cord Blood Processing System
5. The genetics of MLL leukemogenesis
6. Genesis Technology Group Retains CCG Elite
7. Researchers chart the genetic mechanisms behind the genesis of fat cells
8. Tissue Genesis Signs Exclusive Distribution and License Agreement with SpineSmith
9. ThermoGenesis Corp. Reports First Quarter 2008 Results
10. Cardiogenesis Receives FDA Approval for PEARL 5.0 Robotic Hand Piece
11. Genesis Pharmaceuticals Announces Results for The First Quarter of Fiscal Year 2008

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/7/2009)..., WASHINGTON, Nov. 7 Wi...ng, antichoice extremists are holding the entire b...They are demanding that the bill go far beyond the... incorporated into the original bill. In an outra...early Saturday afternoon, antichoice Democrats are...
(Date:11/7/2009)..., WASHINGTON, Nov. 7 Sp...ress availability this afternoon following a Democ...non Caucus Room. Below are the Speaker,s opening ...es, it was a great occasion for us to receive the ... will be making history with our vote and making p...
(Date:11/7/2009)...s should not assume that all youth will rebel, exp...ews) -- Teens are more likely to behave badly if t...found. , "Parents who believe they are simply bein...lfilling prophecy," Christy Buchanan, a psychology... of the study, said in a university news release. ...
(Date:11/7/2009)... In the current economic clima...s closely and are only spending money on what that... weight loss surgeon David D. Kim believes that i...men and women to receive treatment to improve thei...gery affordable to patients in this tough economy ...
(Date:11/6/2009)...AQ: CRME TSX: COM , VANCOUVER, Nov. 6 /PRNewsw...RME / TSX: COM) today announced that it will repo...eptember 30, 2009 on the morning of Monday, Novemb...ll and webcast at 9:00am Eastern (6:00am Pacific) ...he conference call, please dial 416-695-7806 or 88...
Breaking Medicine News(10 mins):Health News:Pelosi Remarks Following House Democrats' Meeting with President Obama 2Health News:Bad-Behaving Teens May Be Living Up to Expectations 2Health News:Dallas Bariatric Surgeon Offers Multiple Options for Patients Considering Weight Loss Surgery in a Rough Economy 2Health News:Dallas Bariatric Surgeon Offers Multiple Options for Patients Considering Weight Loss Surgery in a Rough Economy 3Health News:Cardiome to Release Third Quarter Results 2Health News:Cardiome to Release Third Quarter Results 3
...ther Analysis of Evaluator Assessment Scale and Ph...nnounced Phase III Study as a ... Pivotal Phase III Clinical Program in Wrinkles -,...III program investigating the Isolagen,Therapy(TM)...
...27 Going through airport security,can be such a h...lts all,get taken off, taken out, scanned, examine...y safe form of electromagnetic radiation, may resh...ory, along with collaborators in Turkey and Japan,...
... Nov. 27 U.S. Career Institute, a,nationally accr...lout of,the first ever DETC accredited Medical Ass...nt course is their 18th course to date, 6th in the... Rohr,president of U.S. Career Institute. "Our mis...
... 27 A new, free white paper advises,medical devic...ing the,right electronics manufacturing services (...,s available free to download at, http://www.feder...th the equally,essential need to get new products ...
...nology beat CT in spotting tumors early , TUESDAY,...g may improve the diagnosis and treatment of lung ...ral recent studies. , Tumor imaging is frequently ...n biochemical processes that may alert doctors to ...
...[Brown University] Heavy smoking and drinking are...th human papillomavirus type 16 (HPV16), a common ...nother known risk factor for head and neck cancer,...increase the risk of contracting head and neck can...
Other Medicine News:Health News:Isolagen Modifies Ongoing Clinical Program for Acne Scars 2Health News:Isolagen Modifies Ongoing Clinical Program for Acne Scars 3Health News:New T-ray Source Could Improve Airport Security, Cancer Detection 2Health News:New T-ray Source Could Improve Airport Security, Cancer Detection 3Health News:New T-ray Source Could Improve Airport Security, Cancer Detection 4Health News:U.S. Career Institute Launches 1st Ever DETC Accredited Medical Assistant Course 2Health News:White Paper Details How to Choose the Right EMS Provider for Medical Products Outsourcing 2Health News:PET Scans Could Boost Lung Cancer Diagnosis 2Health News:Drinking and smoking don't boost HPV-related cancer risk 2
(Date:11/6/2009)...ll/ -- Keryx Biopharmaceuticals, Inc. (Nasdaq: KE...ber 10, 2009 at 8:30 a.m. EST to discuss the third...ok for the remainder of 2009. Ron Bentsur, Chief ...ll. Keryx will announce its financial results for... to the call. ,, In order to participate in the...
(Date:11/6/2009)...l/ -- Caraco Pharmaceutical Laboratories, Ltd. (NY...e ophthalmic solution, 0.5% following a final appr...) for Sun Pharma,s Abbreviated New Drug Applicatio...on on the first day following patent expiration. T...alent to Acular® Ophthalmic Solution, 0.5%, f...
(Date:11/5/2009)...wswire-FirstCall/ -- Transcept Pharmaceuticals, In...mpany focused on the development and commercializa...t therapeutic needs in the field of neuroscience, ...ference with management to discuss third quarter 2...09, at 5:00 p.m. Eastern Standard Time. Financial...
Breaking Medicine Technology:Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Third Quarter 2009 Financial Results on Tuesday, November 10, 2009 at 8:30 a.m. EST 2Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Acular(R) Opthalmic Solution 2Transcept Pharmaceuticals to Report Third Quarter 2009 Results and Host Conference Call on November 12 2Keryx Biopharmaceuticals Phase 2 Data of KRX 0401 28Perifosine 29 in the Treatment of Advanced Metastatic Renal Cell Cancer Selected for Oral Present 4998 1Keryx Biopharmaceuticals Phase 2 Data of KRX 0401 28Perifosine 29 in the Treatment of Advanced Metastatic Renal Cell Cancer Selected for Oral Present 4998 2Keryx Biopharmaceuticals Phase 2 Data of KRX 0401 28Perifosine 29 in the Treatment of Advanced Metastatic Renal Cell Cancer Selected for Oral Present 4998 3Communication problems in dementia care cause physical strain 57029 1Communication problems in dementia care cause physical strain 57029 2Evolution still scientifically stable 9912 1Evolution still scientifically stable 9912 2
...he University of,Maryland,s Maryland Industrial Pa...oval of 18 new collaborative research projects bet...Worth $4.4 million, the new projects combine $3 mi...n from the Maryland Industrial,Partnerships Progra...rch that furthers the,development of high-tech pro...
...b. 21 Flawed policies and,bad decisions at the FD...,clinical trials which now take an average of one ... This has delayed and even prevented the,availabil... in increased,death and suffering for patients and...in the United States., It,s time to reform the FD...
Other Medicine Technology:UM Maryland Industrial Partnerships Program Approves 18 Collaborative Research Projects, Worth $4.4 Million, Between University Faculty, State Technology Companies 2UM Maryland Industrial Partnerships Program Approves 18 Collaborative Research Projects, Worth $4.4 Million, Between University Faculty, State Technology Companies 3Cancer Cure Coalition Proposes Major Changes at the FDA 2Cancer Cure Coalition Proposes Major Changes at the FDA 3
Hatsis Tying Forceps
Castroviejo Straight Tying Forceps
Microsurgical straight forceps
Curved tying forceps
Medicine Products: